Compare LKSP & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LKSP | ABOS |
|---|---|---|
| Founded | 2024 | 1996 |
| Country | United States | United States |
| Employees | 2 | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 161.3M | 147.5M |
| IPO Year | 2025 | 2021 |
| Metric | LKSP | ABOS |
|---|---|---|
| Price | $10.28 | $1.99 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $7.60 |
| AVG Volume (30 Days) | 69.5K | ★ 545.3K |
| Earning Date | 01-01-0001 | 10-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $114.22 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.89 | $1.50 |
| 52 Week High | $10.30 | $3.60 |
| Indicator | LKSP | ABOS |
|---|---|---|
| Relative Strength Index (RSI) | 69.08 | 43.66 |
| Support Level | $10.09 | $1.62 |
| Resistance Level | N/A | $2.77 |
| Average True Range (ATR) | 0.01 | 0.14 |
| MACD | -0.00 | 0.04 |
| Stochastic Oscillator | 66.67 | 68.18 |
Lake Superior Acquisition Corp is a blank check company.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.